Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 269 No 7223 p665-670
9 November 2002


News summary

Branch meetings   Future Events   Conferences  

Restrictions on OTC advertising to go Rules that restrict advertising non-prescription medicines to the public are to be scrapped...[more]

Lancet articles are disappointing and biased according to ABPI The first of a series of four articles published in The Lancet, aimed at scrutinising the pharmaceutical industry, has been condemned as disappointing and biased by the Association of the British Pharmaceutical Industry...[more]

Cardiac risk similar for thioridazine and haloperidol Overall, the risk of cardiac events in patients with schizophrenia treated with thioridazine is no worse than that for patients treated with haloperidol, a cohort study has shown. However, thioridazine may have a higher risk at high doses and so should be prescribed at the lowest dose needed to obtain an optimal therapeutic effect...[more]

Europe to block re-importation of medicines destined for Third World It will soon be a crime to re-import into Europe medicines sold cheaply to developing countries to treat AIDS/HIV, tuberculosis or malaria...[more]

Pharmaceutical suppliers are against patient leaflet photocopying proposals Eleven organisations representing pharmacies, wholesalers and manufacturers of pharmaceuticals have voiced concern about the Medicines Control Agency's proposals to allow pharmacists to photocopy patient information leaflets. They have called on the MCA to withdraw the proposals...[more]

GPs override drug interaction alerts without checking Almost one-quarter of general practitioners surveyed admitted that they frequently override computerised drug interaction alerts without investigating them further...[more]

HRT safety message update in latest issue of MCA/CSM bulletin The benefits of hormone replacement therapy over the short term still outweigh the risks for most women who take it, according to the latest safety update from the Medicines Control Agency and the Committee on Safety of Medicines...[more]

NICE issues type 2 diabetes guidance People with type 2 diabetes who have not yet developed cardiovascular disease should have their coronary heart disease risk estimated at least annually, according to recommendations from the National Institute for Clinical Excellence...[more]

Digoxin is safer in men than in women, study claims Digoxin may increase the risk of death among women who have heart failure and depressed left ventricular systolic function, but not among men, according to American researchers...[more]

New antiviral available to treat influenza The antiviral oseltamivir (Tamiflu) is now available for the treatment and prevention of influenza...[more]

WHO identifies global priorities The World Health Organization has highlighted 10 factors that it considers to be the most globally important risks to human health...[more]

Infliximab exerts prolonged response even after the treatment is stopped Infliximab (Remicade), used to treat rheumatoid arthritis (RA), produces a prolonged therapeutic response even after the drug has been withdrawn, new data show...[more]

Arthritis patients benefit when leflunomide is added Adding leflunomide (Arava) to methotrexate therapy produces clinical benefits for patients with rheumatoid arthritis (RA) and is generally well tolerated, a new study shows...[more]

Transdermal selegiline effective treatment for major depression Transdermal selegiline is an effective and well-tolerated treatment for adults with major depression, a new study shows...[more]

Use of low-dose tricyclics justified The use of tricyclic antidepressants at lower-than-recommended doses is justified, say the authors of a systematic review...[more]

Presence of a pharmacy sign of street friendliness Pharmacy accessibility is one of the measures of the friendliness of local streets in London...[more]

Pharmacist loses repetitive dispensing strain injury appeal A pharmacist who claimed that checking prescriptions while working for Boots The Chemists had given him a repetitive strain injury in his left shoulder has lost an appeal on his case...[more]

Cornish pharmacy wins grant for collection and delivery service A community pharmacy in rural Cornwall has won a £9,000 grant from the Countryside Agency to help it run a prescription collection and delivery service in and around the village of St Just at the westerly tip of the county...[more]

Welsh GPs issued 46m prescriptions General practitioners in Wales issued prescriptions for 46 million items at a cost of £456m during 2001–02, according to new figures from the National Assembly for Wales, equivalent to 15.9 items and £156.91 net ingredient cost per person...[more]

Salt intake levels for children Draft recommendations on safe salt intake levels, including those for children, have been issued by the Food Standards Agency...[more]

Chief pharmacist says modernisation will shatter rigid NHS demarcation lines The Government is determined to shatter old, rigid demarcation lines that hold back staff and slow down patient care. So said Dr Jim Smith, chief pharmaceutical officer for England, at the National Pharmaceutical Association's October management board meeting...[more]

Pharmacist opens new trauma unit The former chief executive of the Pharmaceutical Services Negotiating Committee, Dr Alan Smith, FRPharmS, officially opened a new trauma unit at the John Radcliffe Hospital in Oxford last month...[more]

Cannabis medicines on track GW Pharmaceuticals announced positive preliminary results for its cannabis-based medicines from four phase III trials this week...[more]

Head lice prefer not to jump Head lice are particular about what will persuade them to move from one hair to another, Australian researchers have found...[more]


AAH restructures marketing...[more]

Tesco opens Nutri Centre...[more]

Back to Top

  * PDF files on PJ Online require Acrobat Reader 4 or later.


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal